secwatch / observer
8-K filed April 9, 2025, 7:59 PM ET ticker LIPO CIK 0001347242
other material confidence high sentiment neutral materiality 0.40

Lipella increases designated Series C preferred shares from 1,050,000 to 1,260,000

LIPELLA PHARMACEUTICALS INC.

item 5.03item 3.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LIPELLA PHARMACEUTICALS INC.: Increased the number of designated Series C Voting Convertible Preferred Stock shares from 1,050,000 to 1,260,000 (effective 2025-04-08).

Change
charter amendment
Effective
2025-04-08
Exact text from the filing
On April 8, 2025, the Company filed a Certificate of Amendment of Certificate of Designation of Preferences, Rights and Limitations of Series C Voting Convertible Preferred Stock (the “Series C Certificate of Amendment”) with the Secretary of State of the State of Delaware. The Series C Certificate of Amendment amended the Certificate of Designation of Preferences, Rights and Limitations of Series C Voting Convertible Preferred Stock of the Company (the “Certificate of Designation”) to increase the number of shares of the Company’s Series C Voting Convertible Preferred Stock, par value $0.0001 per share, designated pursuant to the Certificate of Designation from 1,050,000 shares to 1,260,000 shares.
View on SEC.gov

Browse all governance changes →

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR
accession 0001753926-25-000604
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.